Investigating how Alzheimer's genetic risk affects dementia in Parkinson's disease
The Role of Alzheimer's Disease Genetic Risk in Predicting Parkinson's Disease Dementia
This study is looking at how certain genes linked to Alzheimer's might affect memory and thinking in people with Parkinson's disease, and it hopes to find new ways to help those experiencing dementia.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10892147 on NIH RePORTER |
What this research studies
This research explores the connection between genetic risk factors for Alzheimer's disease and the development of dementia in individuals with Parkinson's disease. It aims to understand how these genetic factors may predict cognitive decline and the presence of specific biomarkers associated with Alzheimer's pathology. By analyzing data from various research cohorts, the study seeks to identify patterns that could lead to new treatment strategies for dementia in Parkinson's patients. Participants may contribute to a better understanding of the neurobiology underlying these conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Parkinson's disease, particularly those who may be at risk for developing dementia.
Not a fit: Patients without a diagnosis of Parkinson's disease or those who do not have genetic risk factors for Alzheimer's may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for predicting and potentially treating dementia in patients with Parkinson's disease.
How similar studies have performed: Previous research has shown promising results in understanding the relationship between Alzheimer's pathology and cognitive decline in Parkinson's disease, suggesting that this approach may yield valuable insights.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Tropea, Thomas Francis — University of Pennsylvania
- Study coordinator: Tropea, Thomas Francis
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.